APO PHARM ApS: Financial statements 2023
CVR: 15226072
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
APO PHARM ApS (CVR 15226072) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,384,571 and a net result of DKK 292,960 compared with DKK 253,739 the year before. That is an increase of 8.4% compared with the year before. Equity in the 2023 report amounted to DKK 684,226. The solvency ratio was 40.5%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 1,384,571
- Profit/Loss
- DKK 292,960
- Equity
- DKK 684,226
- Total Assets
- DKK 1,691,204
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.4 mio. | 293 t. | 684 t. | 4 |
| 2022 | - | 1.3 mio. | 254 t. | 691 t. | 6 |
| 2021 | - | 1.7 mio. | 566 t. | 1 mio. | 6 |
| 2020 | - | 2.1 mio. | 678 t. | 1.1 mio. | 6 |
| 2019 | - | 1.8 mio. | 748 t. | 1.1 mio. | 5 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout APO PHARM ApS
APO PHARM ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 1991. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VITALISTEN ApS. The management consists of Helge Larsen. The board consists of Hanne Vesti Petersen and Helge Larsen. The company is owned by VESTI LARSEN ApS. The company has 7 employees (2026). In 2025, the company reported a gross profit of DKK 1,481,073 and a net result of DKK 26,824 compared with DKK 121,257 the year before. Equity in the 2025 report amounted to DKK 332,307.